FUSION POLYPEPTIDES AND USES THEREOF

The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors c...

Full description

Saved in:
Bibliographic Details
Main Authors SCHEERER, Nina Alexandra, JÖRISSEN, Hannah, LEINEWEBER, Kirsten, WILMEN, Andreas
Format Patent
LanguageEnglish
French
German
Published 04.11.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
AbstractList The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
Author SCHEERER, Nina Alexandra
JÖRISSEN, Hannah
LEINEWEBER, Kirsten
WILMEN, Andreas
Author_xml – fullname: SCHEERER, Nina Alexandra
– fullname: JÖRISSEN, Hannah
– fullname: LEINEWEBER, Kirsten
– fullname: WILMEN, Andreas
BookMark eNrjYmDJy89L5WRQcQsN9vT3Uwjw94kMcA0I8XRxDVZw9HNRCA0GMkI8XINc_d14GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRpbGFmbGBo6ExEUoAK-UkhQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FUSIONSPOLYPEPTIDE UND VERWENDUNGEN DAVON
POLYPEPTIDES DE FUSION ET LEURS UTILISATIONS
ExternalDocumentID EP2938630A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2938630A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:32:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2938630A13
Notes Application Number: EP20130814133
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151104&DB=EPODOC&CC=EP&NR=2938630A1
ParticipantIDs epo_espacenet_EP2938630A1
PublicationCentury 2000
PublicationDate 20151104
PublicationDateYYYYMMDD 2015-11-04
PublicationDate_xml – month: 11
  year: 2015
  text: 20151104
  day: 04
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies BAYER PHARMA AKTIENGESELLSCHAFT
RelatedCompanies_xml – name: BAYER PHARMA AKTIENGESELLSCHAFT
Score 3.006137
Snippet The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title FUSION POLYPEPTIDES AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151104&DB=EPODOC&locale=&CC=EP&NR=2938630A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgYAbDBDjpRym3ioW2vVxqNDWpCqItdVo0ThNDSTSLmNiRfx9nGgbXOBmJZKTWPrsOI5tgF7gyFoI5dpKhVQX1XZsHTyyqRB9GnhChSZcMM68tHIfpoNpC-abXBhTJ_TLFEdERL0i3hujr5c_j1jM_K1c3Yg5Dr3fJWXErLV3jOZLd7Nlo4gXOctjK46RsrJJhFYt8Jz-EB2lHbxF-xoM_Hmkk1KWvy1Kcgi7BTJbNEfQkosO7Mebxmsd2Buv491IrqG3OoZeUmm9R4r88aXgRXnP-BMZZoxUqBFJmfIJz5MTIAkv49TG5Wbbo814sd2Ycwpt9PjlGRDphbdvKlB-UAduSFU9qH2q_6-EyvepdLvQ_ZPN-T9zF3CgZWRS6dxLaDcfn_IKbWojro00vgETaHbJ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCDGs4ept4qVdn0cKrQ1qTroS6NF4zQ1o5F2GRMr4u_jRN3gAjcrkZzE0mfHcWwD9B2jKhnjpsa5q4ui2oYmgkeazthAdyzGXRkuiBMrLMzH2XDWguU2F0bWCf2SxRERUQvEey319frnEYvIv5WbO7bEofeHIPeI2njHaL5EN1sy9miWktRXfR8pNZl6aNUcyxiM0FHawxu2LcBAX8YiKWX926IER7CfIbNVfQytatWFjr9tvNaFg7iJdyPZQG9zAv2gEHpPydLoNaNZPiH0WRklRClQIyp5SKc0DU5BCWjuhxouN98dbU6z3caMM2ijx1-dg1JZ7v0bd7jtlI7p6rwclrYu_q-43Lb1yuxB7082F__M3UInzONoHk2Sp0s4FPKSaXXmFbTrj8_qGu1rzW6kZL4B0EN5vA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FUSION+POLYPEPTIDES+AND+USES+THEREOF&rft.inventor=SCHEERER%2C+Nina+Alexandra&rft.inventor=J%C3%96RISSEN%2C+Hannah&rft.inventor=LEINEWEBER%2C+Kirsten&rft.inventor=WILMEN%2C+Andreas&rft.date=2015-11-04&rft.externalDBID=A1&rft.externalDocID=EP2938630A1